FDA granted accelerated approval to camizestrant, the first cancer therapy that starts when a blood test finds resistance before scans show progression.
A Blood Test, Not a Scan, Now Triggers This Breast Cancer Treatment Switch Under Accelerated Approval
by | Sep 6, 2026 | Uncategorized | 0 comments
Recent Comments